Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2011-06-28
2011-06-28
Wen, Sharon (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100, C530S388100, C530S389100
Reexamination Certificate
active
07968689
ABSTRACT:
The present invention relates to human secreted polypeptides, and isolated nucleic acid molecules encoding said polypeptides, useful for diagnosing and treating immune disorders and diseases. Antibodies that bind these polypeptides are also encompassed by the present invention. Also encompassed by the invention are vectors, host cells, and recombinant and synthetic methods for producing said polynucleotides, polypeptides, and/or antibodies. The invention further encompasses screening methods for identifying agonists and antagonists of polynucleotides and polypeptides of the invention. The present invention further encompasses methods and compositions for inhibiting or enhancing the production and function of the polypeptides of the present invention.
REFERENCES:
patent: 4923813 (1990-05-01), Hecht et al.
patent: 5011912 (1991-04-01), Hopp et al.
patent: 5194596 (1993-03-01), Tischer et al.
patent: 5350836 (1994-09-01), Kopchick et al.
patent: 5536637 (1996-07-01), Jacobs
patent: 7368531 (2008-05-01), Rosen et al.
patent: 7411051 (2008-08-01), Rosen et al.
patent: 2007/0224663 (2007-09-01), Rosen et al.
patent: WO 91/04328 (1991-04-01), None
patent: WO 97/07198 (1997-02-01), None
patent: WO 99/27098 (1999-06-01), None
Anisowicz et al,, “A Novel Protease Homolog Differentially Expressed in Breast and Ovarian Cancer”Mol. Med. 2(5):624-636 (Sep. 1996).
Barton et al., “Protein sequence alignment and database scanning”, Protein Structure Prediction, A Practical Approach, IRL Press at Oxford University Press, Oxford, UK, pp. 31-63 (1996).
Clark et al. “The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis”Brit. J. Cancer81(6):1002-1008 (1999).
desJardins et al, “Prediction of enzyme classification from protein sequence without the use of sequence similarity,”Amer. Assoc. Artific. Intell. pp. 92-99 (1997).
Everett et al., “Pendred Syndrome is Caused by Mutations in a Putative Sulphate Transporter Gene (PDS),”Nat. Genet. 17:411-422 (1997).
Ferrari et al., “Prospective Analysis of Prostate-Specific Markers in Pelvic Lymph Nodes of Patients With High-Risk Prostate Cancer”J. Natl. Cancer Inst. 89(20):1498-1504 (Oct. 15, 1997).
GenBank Database, Accession No. NP—009199 (Mar. 27, 2009).
GenBank Database, Accession No. EAX05395 (Dec. 18, 2006).
GenBank Database, Accession No. CAB46921 (Jan. 15, 2009).
George et al., “Current Methods in Sequence Comparison and Analysis”, Macromolecular Sequencing and Synthesis, Selected Methods and Applications, D.H. Schlesinger (ed,) Alan R. Liss, Inc., New York, NY, pp. 127-149 (1988).
Gygi et al. “Correlation Between Protein and mRNA Abundance in Yeast”Mol. Cell. Biol. 19(3):1720-1730 (Mar. 1999).
Hammond et al,, “Issues and Barriers to Development of Clinically Useful Tumor Markers: A Development Pathway Proposal,”Semin. Oncol. 29(3):213-221 (2002).
Haynes et al., “Proteome analysis: Biological assay or data archive?”Electrophoresis19:1862-1871 (1998).
Holm, L., “Unification of protein families,”Curr. Opin. Struct. Biol. 8:372-379 (1998).
Jacobs et al., “A Novel Method for Isolating Eukaryotic cDNA Clones Encoding Secreted Proteins”,J. Cell. Biochem. Suppl. abstract No. C1-207 (1995).
Jacobs et al,, “A genetic selection for isolating cDNAs encoding secreted proteins,”Gene198:289-296 (1997).
Kaufman et al., “Transgenic analysis of a 100-kb human B-globulin cluster-containing DNA fragment propagated as a bacterial artificial chromosome,”Blood94(9):3178-3184 (1999).
Lee, et al., “Z39Ig is expressed on macrophages and may mediate inflammatory reactions in arthritis and atherosclerosis,”Journal of Leukocyte Biology, 80:922-928 (Oct. 2006).
Maida et al., “Ovarian endometrioid adenocarcinoma with ectopic production of alpha-fetoprotein,”Gynecol. Oncol. 71(1):133-136 (Oct. 1998) (abstract only).
Ngo et al., “Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox,” in Merz and Le Grand (Eds.), The Protein Folding Problem and Tertiary Structure Prediction, Birkhauser Boston, pp. 491-495 (1994).
Palù et al., “In pursuit of new developments for gene therapy of human diseases,”J. Biotech. 68:1-13 (1999).
Pennica et al,, “WISPgenes are members of the connective tissue growth factor family that are up-regulated in Wnt-1-transformed cells and aberrantly expressed in human colon tumors,”Proc. Natl. Acad. Sci. USA95:14717-14722 (Dec. 1998).
Phillips, A.J., “The challenge of gene therapy and DNA delivery,”J. Pharm. Pharmacol. 53:1169-1174 (2001).
Roget's International Thesaurus, Third Ed., Thomas Y. Crowell Co., 1962, p. 65.
Scott et al., “The Pendred Syndrome Gene Encodes a Chloride-iodide Transport Protein,”Nat. Genet. 21:440-443 (1999).
Seffernick et al., “Melamine Deaminase and Atrazine Chlorohydrolase: 98 Percent Identical but Functionally Different,”J. Bacteriol. 183(8):2405-2410 (Apr. 2001).
Suzuki et al., “An Introduction to Genetic Analysis”, Third Edition, W.H. Freeman and Company, New York, NY (1986).
Vukicevic et al., “Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein 7)”Proc. Natl. Acad. Sci. USA93:9021-9026 (Aug. 1996).
Wang et al., “Rapid analysis of gene expression (RAGE) facilitates universal expression profiling,”Nucl. Acids Res., 27(23):4609-4618 (1999).
Wells, J.A., “Additivity of Mutational Effects in Proteins,”Biochemistry, 29(37):8509-8517 (1990).
Witkowski et al., “Conversion of Beta-Ketoacyl Synthase to a Malonyl Decarboxylase by Replacement of the Active-Site Cysteine with Glutamine,”Biochemistry38:11643-11650 (1999).
Zang, et al., “To be or not to be B7,”The Journal of Clinical Investigation, 116(10):2590-2593 (Oct. 2006).
Helmy et al., “CRIg: A Macrophage Complement Receptor Required for Phagocytosis of Circulating Pathogens,”Cell, vol. 124, pp. 915-927, Supplemental Data, pp. 1-20, Mar. 10, 2006.
Lee et al., “Z39Ig is expressed on macrophages and may mediate inflammatory reactions in arthritis and atherosclerosis,”Journal of Leukocyte Biology, vol. 80, pp. 922-928, Oct. 2006.
Pellagatti et al., “Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients,”PNAS, vol. 104, No. 27, pp. 11406-11411, Jul. 3, 2007.
Tanaka et al., “Expansion of a unique macrophage subset in rheumatoid arthritis synovial lining layer,”Clinical and Experimental Immunology, vol. 154, pp. 38-47, 2008.
Van Loo et al., “T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response,”Haematologica, vol. 95, No. 3, pp. 440-448, 2010.
Vogt et al., “VSIG4, a B7 family-related protein, is a negative regulator of T cell activation,”The Journal of Clinical Investigation, vol. 116, No. 10, pp. 2817-2826, Oct. 2006.
Wiesmann et al., “Structure of C3b in complex with CRIg gives insights into regulation of complement activation,”Nature, vol. 444, pp. 217-220, Supplement pp. 1-16, Nov. 2006.
Moore Paul A.
Rosen Craig A.
Ruben Steven M.
Human Genome Sciences Inc.
Wen Sharon
LandOfFree
Antibodies to HSDEK49 polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies to HSDEK49 polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to HSDEK49 polypeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2691418